Woodline Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Woodline Partners's ABBV Position: Q3 2026 in Review
Woodline Partners reduced its AbbVie (ABBV) stake by 55% in Q3 2026, selling an estimated $128M and leaving 406,941 shares worth $106M. The position accounts for 0.32% of the portfolio, ranked #53.
Woodline Partners first reported a position in ABBV in Q1 2021 and has held it in 21 quarters since. The position peaked at $228M in Q2 2026. 4,285 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Woodline Partners held 406,941 shares of AbbVie worth $106M as of Q3 2026.
- Woodline Partners sold 500,422 AbbVie shares in Q3 2026, an estimated $128M.
- AbbVie made up 0.32% of Woodline Partners's portfolio in Q3 2026, its #53 holding.
- Woodline Partners first reported a position in AbbVie in Q1 2021 and has held it in 21 quarters since.
- Woodline Partners's AbbVie position peaked at $228M in Q2 2026.
- 4,285 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Woodline Partners's 13F filing for Q3 2026, filed 16 Nov 2026.